Pipeline DCVax - Prostate: Phase III DCVax - Brain: Phase II Clinical Trial Sites Los Angeles, UCLA Medical Center Linda Liau, MD Phone: 310-794-5664 E-mail: lliau@mednet.ucla.edu Detroit, Henry Ford Health System Tom Mikkelsen, MD Phone: 313-916-8641 E-mail: nstom@neuro.hfh.edu New Jersey, Overlook Hospital Michael L. Gruber, MD Phone: 908-522-5914 E-mail: michael.gruber@nyumc.org New York, NYU Cancer Institute Michael L. Gruber, MD Phone: 212-731-5577 E-mail: michael.gruber@nyumc.org University of Cincinnati Margie Gerena-Lewis, MD Phone: 513-584-6178 E-mail: lewism2@ucmail.uc.edu University of Illinois at Chicago John Villano, MD Phone: 312-996-6768 E-mail: jvillano@uic.edu Virginia Piper Cancer Institute John Trusheim, MD Phone: 612-863-8716 E-mail: anna.mehlhoff@allina.com University of Michigan Jason Heth, MD Phone: 734-615-4486 E-mail: jheth@umich.edu University of Hospitals of Cleveland Andrew E. Sloan, MD Phone: 216-844-6054 E-mail: andrew.sloan@uhhospitals.org Baylor Research Institute Karen Fink, MD, PhD Phone: 214-820-8690 E-mail: karenfin@baylorhealth.edu

Patient Inquiry Please follow the instructions below to access the Patient Inquiry system: CLICK HERE When prompted with a website security certificate error, please click on "Continue to this website (not recommended)". Follow the instructions on the new page to complete your inquiry.

Copyright © 2008 Northwest Biotherapeutics, Inc. | Forward-Looking Statements | Legal Disclaimer | Privacy Policy